Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study

Duo Huang, Yang-Yang Cheng, Pak-Hei Chan, Jojo Hai, Kai-Hang Yiu, Hung-Fat Tse, Ka-Lam Wong, Katherine Fan, Ying Wah Li, Woon-Leung Ng, Cheuk-Wan Yim, Cheuk-hon John Wong, Lai-Shan Tam, Priscilla C.H. Wong, Chi-Yuen Wong, Chup-Hei Ho, Alexander M.H. Leung, Chi-Chiu Mok, Ho Lam, Chak-Sing Lau, Tommy Cheung, Carmen Ho, Sharon W.Y. Law, Esther W. Chan, Li-Xue Yin, Wen-Sheng Yue, Toi Meng Mok, Mario Alberto Evora, Chung-Wah Siu

Source: ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017
Journal Issue: January
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Duo Huang, Yang-Yang Cheng, Pak-Hei Chan, Jojo Hai, Kai-Hang Yiu, Hung-Fat Tse, Ka-Lam Wong, Katherine Fan, Ying Wah Li, Woon-Leung Ng, Cheuk-Wan Yim, Cheuk-hon John Wong, Lai-Shan Tam, Priscilla C.H. Wong, Chi-Yuen Wong, Chup-Hei Ho, Alexander M.H. Leung, Chi-Chiu Mok, Ho Lam, Chak-Sing Lau, Tommy Cheung, Carmen Ho, Sharon W.Y. Law, Esther W. Chan, Li-Xue Yin, Wen-Sheng Yue, Toi Meng Mok, Mario Alberto Evora, Chung-Wah Siu. Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study. ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Pulmonary hypertension in systemic lupus erythematosus – a retrospective analysis
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Source: Eur Respir Rev 2011; 20: 277-286
Year: 2011



Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE)
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020

Pulmonary arterial hypertension and systemic lupus erythematosus
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Lung involvement in systemic lupus erythematosus (SLE) - our own experience
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018
Year: 2019



On diagnostics of pneumonitis in patients with lupus erythematosus (LE)
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005

Cardio-pulmonary exercise testing in systemic lupus erythematosus patients
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005

Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Lung abnormalities in patients with systemic lupus erythematosus
Source: Eur Respir J 2001; 18: Suppl. 33, 225s
Year: 2001

Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011


Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies?
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007

Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success?
Source: Eur Respir Rev 2011; 20: 218-219
Year: 2011


Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease
Source: Eur Respir Monogr 2019; 86: 106-123
Year: 2019